July 10, 2017

TimesNow NewHour capture views of Dr Piyush Gupta about the GST and how pharma industry is ready for GST

October 26, 2016

One of the fasted growing industries in the world, the pharmaceuticals industry is also one of the biggest contributors to the world economy. The major sales of the pharmaceuticals products come from the "Triad (US, EU and Japan) in the

October 06, 2016

Expopharm is going to held on 12th Oct to 15th Oct, 2016 in Munich, Germany. It is the largest pharmaceutical trade fair in Europe, where you can meet various like minded pharmacists, key decision-makers, health professionals and pharma leader

September 20, 2016

2016 Partnerships in Clinical trials (PCT) part of Boston Biotech Week taking place from 5th - 7th October is your chance to learn about the Biologic opportunity!As per current reports in public domain a huge market opportunity lies ahead for

September 07, 2016

For third time in a row, GNH India will be attending the 9th Biosimilars Congregation on 22nd September 2016 at The Lalit Hotel, Mumbai, India.With top pharmaceutical, biotechnology and regulatory representatives attending this event; agenda of this conference is

February 08, 2016

Sourcing Comparators / Biosimilars have always been an Achilles heel in any Clinical trial. These seeming simple products are the “Check Nuts” that can make the entire trial go haywire if supply is delayed. The challenge of sourcing Comparators / Biosimilars gets

June 29, 2013

Crizotinib (trade name Xalkori, Pfizer, is an anti-cancer drug acting as an ALK (anaplastic lymphoma kinase) and ROS1 (c-ros oncogene 1) inhibitor, approved for treatment of some non-small cell lung carcinoma (NSCLC) in the US and some other countries, and undergoing clinical trials testing its safety and efficacy in anaplastic large cell lymphoma, neuroblastoma, and other advanced solid tumors in both adults and children.Crizotinib has an aminopyridine structure, and functions as a protein kinase inhibitor by competitive binding within the ATP-binding pocket of target kinases. About 4% of patients with non-small cell lung carcinoma

June 28, 2013

The naturally occurring prostaglandin E2 (PGE2) is known in medicine as dinoprostone. It has important effects in labour (softens cervix and causes uterine contraction) and also stimulates osteoblasts to release factors that stimulate bone resorption by osteoclasts. PGE2 is also

June 29, 2013

Orlistat (also known as tetrahydrolipstatin) is a drug designed to treat obesity. It is marketed as a prescription under the trade name Xenical in most countries and is sold over-the-counter as Alli by GlaxoSmithKline in the United Kingdom